MarginsXMarginsX
Home › Markets › Health Care › CPHI

China Pharma Holdings Inc. (CPHI)

CPHI trades on NYSE in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$0.4800
-7.35% on the day
Market cap
$20.7M
Nano cap
Revenue · 2025
$4.1M
-8.5% on 2024
Net income · 2025
-$3.2M
-76.9% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:Revenues), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1106644/000121390026038521/0001213900-26-038521-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerCPHI on NYSE
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryChina
IPO yearNot reported by the screener
SEC CIK0001106644
SEC industry codePharmaceutical Preparations
Incorporated inDE

Financials · 2025

LineValue
Revenue$4.1M
Net income-$3.2M
Operating income-$3.2M
Net margin-76.9%
Operating margin-78.2%
Revenue growth-8.5%
Cash$345K
Total assets$31.0M
P/E (computed)Net income was not positive
P/S (computed)5.0×

Warning signs

Cash runway
26.0 months
$305K cash at June 30, 2026
Share count, 1 year
+1218.9%
2025-08-07 to 2026-08-11 · +18715.2% over 3 years
Going-concern doubt
No
10-Q filed August 14, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-08-14
Cash and burn$305K cash; operating cash flow -$35K a quarter.Report 2026-06-30
Shares outstanding43,022,002 (2026-08-11); 3,262,002 a year earlier; 11,432,801 three years earlier. 3y figure adjusted for splits (1-for-50 overall).Cover page 2026-08-11
Reverse splits, 3 years2; latest 1-for-10 on 2025-04-15Source 2025-04-15
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 1 424B5 takedownsLatest 2026-07-23
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorENROME LLP, Singapore, SingaporePCAOB Form AP 2026-04-02
Late filings, 12 months1 NT noticeNT 10-K 2026-04-01
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q2 2026
2026-06-30
$948K-$1.5M-$33K$305K$1.6M$3.9M10-Q 2026-08-14
Q1 2026
2026-03-31
$984K-$1.1M-$55K$168K$1.5M$4.0M10-Q 2026-05-15
Q4 2025
2025-12-31
$1.2M-$1.2M$152K$345K$1.4M$4.1M10-K 2026-04-01
Q3 2025
2025-09-30
$756K-$651K-$204K$268K$1.4M$4.1M10-Q 2025-11-12
Q2 2025
2025-06-30
$1.0M-$528K$274K$600K$1.4M$4.4M10-Q 2026-08-14
Q1 2025
2025-03-31
$1.1M-$786K-$74K$400K$1.2M$4.3M10-Q 2026-05-15
Q4 2024
2024-12-31
$1.1M-$1.2M$299K$627K$1.1M$4.5M10-K 2026-04-01
Q3 2024
2024-09-30
$1.1M-$1.1M-$47K$700K$315K$5.5M10-Q 2025-11-12

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document
PROSPECTUS SUPPLEMENT
424B52026-07-23
Latest annual report
ANNUAL REPORT
10-K2026-04-01
Latest quarterly / interim
QUARTERLY REPORT
10-Q2026-08-14
Latest current report
CURRENT REPORT
8-K2026-07-22
Latest proxy
DEFINITIVE PROXY STATEMENT
DEF 14A2026-11-10

Source: SEC EDGAR submissions feed, 427 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-8.8%
1 month-30.7%
3 months-52.3%
Year to date-57.0%
1 year-65.8%
From 52-week high-93.6%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
IGCIGC Pharma Inc.$0.1750-0.57%$20.4M
TXMDTherapeuticsMD Inc.$1.81-3.21%$20.9M
SHPHShuttle Pharmaceuticals Holdings Inc.$4.24-6.40%$20.2M
CELUCelularity Inc.$0.6191-1.75%$20.1M
AYTUAytu BioPharma Inc.$1.82+1.68%$19.8M
ATOSAtossa Therapeutics Inc.$1.93-1.53%$19.3M
COCPCocrystal Pharma Inc.$0.9777-0.24%$18.8M
RNAZTransCode Therapeutics Inc.$1.35-1.46%$22.9M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier